Novel hexahydropyrrolo[3,4-c]pyrrole CCR5 antagonists

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Drug Discovery

Background:

• CCR5 receptor antagonists are crucial in treating viral infections and inflammatory diseases.
• High-throughput screening (HTS) provides initial hits for drug development.
• Optimizing pharmacokinetic properties is essential for therapeutic efficacy.

Purpose of the Study:

• To develop a novel series of CCR5 antagonists.
• To improve pharmacokinetic properties through structure-activity relationship (SAR) studies.
• To characterize the synthesis, SAR, and biological activity of the new compounds.

Main Methods:

• Information-based drug design approach.
• Structure-activity relationship (SAR) exploration of a lead template.
• Chemical synthesis of novel CCR5 antagonists.
• Biological profiling of synthesized compounds.

Main Results:

• A novel series of CCR5 antagonists was successfully synthesized.
• SAR exploration led to improved pharmacokinetic properties.
• The biological profiles of the developed compounds were elucidated.

Conclusions:

• The information-based approach is effective for developing CCR5 antagonists.
• SAR optimization is key to enhancing drug-like properties.
• The described series represents promising candidates for further investigation.